Table 2.
Provider and patient barriers limiting MAT access (N = 78)
| Barrier | Number (%) of consortia reporting large or moderate impacts (N = 78a) |
|---|---|
| Provider Barriers to MAT Provision | |
| Perceived Clinical Complexity | 28 (36%) |
| Unwillingness to Provide MAT at All or to Capacity | 26 (33%) |
| Negative Stereotypes About Individuals With SUD/OUDb | 25 (32%) |
| Difficulty in Getting OUD Patients Who Present to Engage in Treatment | 36 (46%) |
| MAT Not Seen as a Best Practice | 14 (18%) |
| Patient Barriers to MAT Provision | |
| Mistrust of the Health Care System | 26 (33%) |
| Refusal of MAT as a Treatment Approach | 11 (14%) |
| Individuals in the Community with OUD Are Not Presenting for Treatmentb | 38 (49%) |
| Lack of Insurance (un- or under-insured) | 32 (41%) |
| Logistical Barriers (e.g., transportation, telehealth-related issues such as no internet connection or cell phone) | 54 (69%) |
a Among the 80 consortia included in our main analysis sample, 2 did not complete progress reports, leaving a sample of 78 for the barriers analysis
b One of the 78 consortia did not respond to the Negative Stereotypes About Individuals with SUD/OUD item, and another consortium did not respond to the Individuals in the Community with OUD Are Not Presenting for Treatment item, leaving a sample size of 77 for these two items